BDBM323200 N-[(R)-2-(3-hydroxy-3-o-tolylazetidin-1-yl)-1-(4-methoxybenzyl)-2-oxoethyl]-3-(1H-imidazol-4-yl)propionamide::US9630949, 29

SMILES COc1ccc(C[C@@H](NC(=O)CCc2c[nH]cn2)C(=O)N2CC(O)(C2)c2ccccc2C)cc1

InChI Key InChIKey=FADVKCLWETZHBS-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 323200   

TargetMelanocyte-stimulating hormone receptor(Human)
Galderma Research & Development

US Patent
LigandPNGBDBM323200(N-[(R)-2-(3-hydroxy-3-o-tolylazetidin-1-yl)-1-(4-m...)
Affinity DataEC50:  1.00E+3nMAssay Description:In the presence of an activator (agonist), the melanocortin receptor will activate the cAMP pathway which, via the CRE-Luc vector, will result in the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/20/2019
Entry Details
US Patent